Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Stress Reactivity and Alcohol Craving in AUD
NCT03860753Phase 2Terminated
- Sponsor
- UTHealth Houston
- Start
- Mar 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Pioglitazone with Placebo (2 arms). Primary endpoints: Heart Rate Change During the Cold Pressor Task at 4 weeks, Systolic Blood Pressure Change During the Cold Pressor Task at 4 weeks and 3 more. Started Mar 2019; status: terminated.
02
Drugs
pioglitazone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03860753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03860753.